WA
Waverly Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $749K | Buy |
15,390
+143
| +0.9% | +$6.96K | 0.01% | 687 |
|
|
2025
Q1 | $519K | Sell |
15,247
-248
| -2% | -$8.44K | 0.01% | 760 |
|
|
2024
Q4 | $610K | Sell |
15,495
-3,897
| -20% | -$153K | 0.01% | 637 |
|
|
2024
Q3 | $911K | Buy |
19,392
+1,907
| +11% | +$89.6K | 0.02% | 459 |
|
|
2024
Q2 | $944K | Buy |
17,485
+8,404
| +93% | +$454K | 0.02% | 438 |
|
|
2024
Q1 | $619K | Buy |
9,081
+4,774
| +111% | +$325K | 0.01% | 441 |
|
|
2023
Q4 | $270K | Buy |
+4,307
| New | +$270K | 0.01% | 375 |
|
|
2023
Q3 | – | Sell |
-4,557
| Closed | -$256K | – | 409 |
|
|
2023
Q2 | $256K | Buy |
+4,557
| New | +$256K | 0.01% | 318 |
|